References
- Doll D C, Weiss R B, Issell B F. Mitomycin: ten years after approval for marketing. J Clin Oncol 1985; 3: 276–286
- Ohtsuru M, Ishii Y, Takai S, Higashi H, Kosaki G. Sister chromatid exchanges in lymphocytes of cancer patients receiving mitomycin C treatment. Cancer Res 1980; 40: 477–480
- Burde B, Haim N, Gez E, Polliack A. Acute myeloblastic leukemia following treatment with mitomycin C: a case report. Cancer Chemother Pharmacol 1989; 24: 71
- Bouillet T, Lepage E, Gisselbrecht C, Boiron M. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma. Nouv Rev Fr Hematol 1990; 32: 207–209
- Nakagawa H, Tanaka S, Takashima T, Shizumi Y, Nishigaki H, Horiike S, et al. Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma. Int J Hematol 1991; 54: 213–217
- Philpott N J, Bevan D H, Gordon-Smith E C. Secondary leukaemia after MMM combined modality therapy for breast carcinoma. Lancet 1993; 341: 1289
- Melillo L M, Sajeva M R, Musto P, Perla G, Cascavilla N, Minervini M M, et al. Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer. Leukemia 1997; 11: 2211–2213
- Saso R, Kulkarni S, Mitchell P, Treleaven J, Swansbury G J, Mehta J, et al. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 2000; 83: 91–94
- Nakamori Y, Miyazaki M, Tominaga T, Taguchi A, Shinohara K. Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer. Int J Clin Oncol 2003; 8: 56–9
- Andersen M K, Larson R A, Mauritzson N, Schnittger S, Jhanwar S C, Pedersen-Bjergaard J. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 395–400
- Quesnel B, Kantarjian H, Bjergaard J P, Brault P, Estey E, Lai J L, et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993; 11: 2370–2379
- Smith M A, McCaffrey R P, Karp J E. The secondary leukemias: challenges and research directions. J Natl Cancer Inst 1996; 88: 407–418
- Dissing M, Le Beau M M, Pedersen-Bjergaard J. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?. J Clin Oncol 1998; 16: 1890–1896
- Pedersen-Bjergaard J, Andersen M K, Johansson B. Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. J Clin Oncol 1998; 16: 1897–1898
- Seymour J F, Juneja S K, Campbell L J, Ellims P H, Estey E, Prince H M. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia 1999; 13: 1735–1740
- Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004; 18: 120–125
- Teicher B A, Kowal C D, Kennedy K A, Sartorelli A C. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981; 41: 1096–1099
- Loggie B W, Fleming R A, McQuellon R P, Russell G B, Geisinger K R. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000; 66: 561–568
- Shen P, Levine E A, Hall J, Case D, Russell G, Fleming R, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138: 26–33
- Glehen O, Mithieux F, Osinsky D, Beaujard A C, Freyer G, Guertsch P, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 2003; 21: 799–806